XML 17 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes (Details Narrative) (USD $)
3 Months Ended
Mar. 31, 2015
Income Tax Disclosure [Abstract]  
Deferred tax asset $ 9,796,306us-gaap_DeferredTaxAssetsCapitalLossCarryforwards
Net operating loss carry forwards 28,795,664us-gaap_OperatingLossCarryforwards
Amount of NOL acuired in reverse aquisition fo BMSG 38,616us-gaap_OperatingLossCarryforwardsValuationAllowance
Amount of NOL attributable to Bio-Matrix Scientific Group, Inc. $ 28,757,048BMSN_NetOperatingLossCarryForwardsAttributableToParentAndPartners
Federal Corporate income tax Rate 34.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate